Global Ankylosing Spondylitis Market Report 2024

Ankylosing Spondylitis Global Market Report 2024 – By Treatment Type (Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biological Therapies, Steroids, Physical Therapies, Surgery), By Molecule (Biologics, Biosimilar, Small Molecules), By Route of Administration (Parenteral, Oral, Other Routes), By Application (Juveniles, Adults), By End User (Hospitals, Clinics, Research Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Ankylosing Spondylitis Global Market Report 2023

Proud Members Of

checkslacipN checkaoirsN checkscipN

Ankylosing Spondylitis Market Definition And Segments

Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine and sacroiliac joints (the joints connecting the lower spine to the pelvis). It involves inflammation of the joints and entheses and affects joints, leading to pain, stiffness, and progressive loss of mobility in the spine.

The main treatment of ankylosing spondylitis includes painkillers and non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), biological therapies, steroids, and physical therapies, surgery. Painkillers and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) refer to medications that block the production of certain chemicals in the body that cause pain and swelling, which are used in ankylosing spondylitis treatment to relieve pain and reduce inflammation. Biologics, biosimilars, and small molecules are administered through parenteral, oral, and other routes for applications in juveniles and adults by hospitals, clinics, research laboratories, and other end users.

The ankylosing spondylitis market covered in this report is segmented –

1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biological Therapies, Steroids, Physical Therapies, Surgery

2) By Molecule: Biologics, Biosimilar, Small Molecules

3) By Route of Administration: Parenteral, Oral, Other Routes

4) By Application: Juveniles, Adults

5) By End User: Hospitals, Clinics, Research Laboratories, Other End Users

The ankylosing spondylitis market size has grown strongly in recent years. It will grow from $5.41 billion in 2023 to $5.86 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to hla-b27 discovery, biologic treatments development, pain management approaches, patient advocacy and awareness, NSAIDS and disease modifying drugs.

The ankylosing spondylitis market size is expected to see strong growth in the next few years. It will grow to $7.89 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to personalized medicine approach, novel biologics development, early intervention and screening, lifestyle and diet management, telemedicine and remote monitoring. Major trends in the forecast period include biosimilar availability, targeted pain therapies, patient-reported outcomes (pros) emphasis, community support programs, regenerative medicine exploration.

Ankylosing Spondylitis Market Surges With The Growing Geriatric Population Worldwide

The increasing geriatric population is expected to propel the growth of the ankylosing spondylitis market going forward. The geriatric population refers to an increase in the proportion of elderly people due to changes in the age structure of a population. This demographic shift has increased the number and proportion of people over the age of 60. Ankylosing spondylitis treatment and drugs help to improve mobility and manage pain in the geriatric population having ankylosing spondylitis condition. For instance, in October 2022, according to World Health Organization, a Switzerland-based international public health organization, by 2030, 1 out of 6 people in the world will be aged more than 60 years or above, and in 2020, there was a rise in 1 billion aged people reaching to 1.4 billion. Therefore, the increasing geriatric population is driving the growth of the ankylosing spondylitis market.

Escalating Instances Of Autoimmune Diseases Propel The Ankylosing Spondylitis Market

The increase in instances of autoimmune diseases will boost the ankylosing spondylitis market going forward. Autoimmune diseases are a broad group of disorders characterized by an abnormal immune response in which the immune system mistakenly attacks and damages healthy cells, tissues, and organs. Autoimmune diseases, including ankylosing spondylitis, occur when the immune system mistakenly targets the body's own tissues, leading to inflammation and damage, with genetic predisposition and environmental factors contributing to the development of ankylosing spondylitis, a form of autoimmune arthritis primarily affecting the spine and pelvis. For instance, in May 2023, as per new population-based study by the University of Oxford, a UK-based research university, autoimmune disorders now affect about one in ten individuals. Therefore, the increase in instances of autoimmune diseases will drive the future growth of the ankylosing spondylitis market.

Major companies operating in the ankylosing spondylitis market report are Pfizer Inc., Johnson & Johnson Pvt. Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Amgen Inc., Cedars-Sinai, Viatris Inc., Astellas Pharma Inc., Regeneron Pharmaceuticals Inc., AstraZeneca PLC, UCB Inc., Cipla Inc., Zydus Lifesciences Limited, Celltrion Inc., Hetero Labs Ltd., UCSF Health, Janssen Biotech Inc., Sandoz International GmbH, Reliance Life Sciences Pvt. Ltd., Affibody Medical AB

Advancements In Therapeutic Options Drive Growth In The Ankylosing Spondylitis Market

The advancements in therapeutic options are a key trend gaining popularity in the ankylosing spondylitis market. Companies operating in ankylosing spondylitis are advancing new therapeutic options to sustain their position in the market. For instance, in December 2021, Pfizer Inc., a US-based pharmaceutical and biotechnology company received FDA approval for XELJANZ (tofacitinib) for the treatment of active ankylosing spondylitis. XELJANZ (tofacitinib) is a Janus kinase (JAK) inhibitor effective for five immuno-inflammatory conditions. This medication is effective against intolerance or inadequate response to one or more tumor necrosis factor (TNF) blockers. The XELJANZ (tofacitinib) does not require infusion or injection to deliver the medication.

Focus On Enzymatic And Cellular Assays For Targeted Therapies

Major companies operating in ankylosing spondylitis are focused on developing innovative drugs such as drugs based on enzymatic and cellular assays for the treatment of moderately to severely active rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn’s disease, ankylosing spondylitis, and non-radiographic axial spondylarthritis. Drugs based on enzymatic and cellular assays are pharmaceuticals developed and validated through testing their effects on specific enzymes or cell systems, enabling targeted and precise therapeutic interventions. For instance, in April 2022, AbbVie Inc., a US-based pharmaceutical company, received Food and Drug Administration (FDA) approval, this time for the treatment of ankylosing spondylitis (AS). RINVOQ, a selective JAK inhibitor undergoing investigation across various immune-mediated inflammatory diseases, exhibits heightened inhibitory potency for JAK-1 over JAK-2, JAK-3, and TYK-2 based on enzymatic and cellular assays.

Merck & Co. Inc. Boosts Portfolio With Acquisition Of Prometheus Biosciences Inc.

In April 2021, Merck & Co. Inc., a Germany-based biopharmaceutical, and technology company acquired Prometheus Biosciences Inc. for $10.8 billion. This acquisition broadens, diversifies, and strengthens Merck’s immunology pipeline by adding innovations and novel therapeutics. Prometheus Biosciences Inc. is a US-based biotechnology company and manufacturer of PRA023 used in the treatment of ankylosing spondylitis.

North America was the largest region in the ankylosing spondylitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ankylosing spondylitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ankylosing spondylitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ankylosing spondylitis market consists of sales of nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs (DMARDs), tumor necrosis factor (TNF) inhibitors, interleukin inhibitors, and corticosteroids. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The ankylosing spondylitis market research report is one of a series of new reports from The Business Research Company that provides ankylosing spondylitis market statistics, including ankylosing spondylitis industry global market size, regional shares, competitors with an ankylosing spondylitis market share, detailed ankylosing spondylitis market segments, market trends and opportunities, and any further data you may need to thrive in the ankylosing spondylitis industry. This ankylosing spondylitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Executive Summary

    2. Ankylosing Spondylitis Market Characteristics

    3. Ankylosing Spondylitis Market Trends And Strategies

    4. Ankylosing Spondylitis Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Ankylosing Spondylitis Market Size and Growth

    5.1. Global Ankylosing Spondylitis Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Ankylosing Spondylitis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Ankylosing Spondylitis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Ankylosing Spondylitis Market Segmentation

    6.1. Global Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)

    Disease-Modifying Anti-Rheumatic Drugs (DMARDS)

    Biological Therapies

    Steroids

    Physical Therapies

    Surgery

    6.2. Global Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Biologics

    Biosimilars

    Small Molecules

    6.3. Global Ankylosing Spondylitis Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Parenteral

    Oral

    Other Routes

    6.4. Global Ankylosing Spondylitis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Juveniles

    Adults

    6.5. Global Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Clinics

    Research Laboratories

    Other End Users

    7. Ankylosing Spondylitis Market Regional And Country Analysis

    7.1. Global Ankylosing Spondylitis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Ankylosing Spondylitis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Ankylosing Spondylitis Market

    8.1. Asia-Pacific Ankylosing Spondylitis Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Ankylosing Spondylitis Market

    9.1. China Ankylosing Spondylitis Market Overview

    9.2. China Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Ankylosing Spondylitis Market

    10.1. India Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Ankylosing Spondylitis Market

    11.1. Japan Ankylosing Spondylitis Market Overview

    11.2. Japan Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Ankylosing Spondylitis Market

    12.1. Australia Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Ankylosing Spondylitis Market

    13.1. Indonesia Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Ankylosing Spondylitis Market

    14.1. South Korea Ankylosing Spondylitis Market Overview

    14.2. South Korea Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Ankylosing Spondylitis Market

    15.1. Western Europe Ankylosing Spondylitis Market Overview

    15.2. Western Europe Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Ankylosing Spondylitis Market

    16.1. UK Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Ankylosing Spondylitis Market

    17.1. Germany Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Ankylosing Spondylitis Market

    18.5. France Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Ankylosing Spondylitis Market

    19.9. Italy Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Ankylosing Spondylitis Market

    20.13. Spain Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Ankylosing Spondylitis Market

    21.1. Eastern Europe Ankylosing Spondylitis Market Overview

    21.2. Eastern Europe Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Ankylosing Spondylitis Market

    22.1. Russia Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Ankylosing Spondylitis Market

    23.1. North America Ankylosing Spondylitis Market Overview

    23.2. North America Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Ankylosing Spondylitis Market

    24.1. USA Ankylosing Spondylitis Market Overview

    24.2. USA Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Ankylosing Spondylitis Market

    25.1. Canada Ankylosing Spondylitis Market Overview

    25.2. Canada Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Ankylosing Spondylitis Market

    26.1. South America Ankylosing Spondylitis Market Overview

    26.2. South America Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Ankylosing Spondylitis Market

    27.1. Brazil Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Ankylosing Spondylitis Market

    28.1. Middle East Ankylosing Spondylitis Market Overview

    28.2. Middle East Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Ankylosing Spondylitis Market

    29.1. Africa Ankylosing Spondylitis Market Overview

    29.2. Africa Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Ankylosing Spondylitis Market Competitive Landscape And Company Profiles

    30.1. Ankylosing Spondylitis Market Competitive Landscape

    30.2. Ankylosing Spondylitis Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Johnson & Johnson Pvt. Ltd.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Merck & Co. Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. AbbVie Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Novartis AG

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Ankylosing Spondylitis Market Other Major And Innovative Companies

    31.1. Bristol-Myers Squibb

    31.2. Eli Lilly and Company

    31.3. Gilead Sciences Inc.

    31.4. Boehringer Ingelheim International GmbH

    31.5. Amgen Inc.

    31.6. Cedars-Sinai

    31.7. Viatris Inc.

    31.8. Astellas Pharma Inc.

    31.9. Regeneron Pharmaceuticals Inc.

    31.10. AstraZeneca plc

    31.11. UCB Inc.

    31.12. Cipla Inc.

    31.13. Zydus Lifesciences Limited

    31.14. Celltrion Inc.

    31.15. Hetero Labs Ltd.

    32. Global Ankylosing Spondylitis Market Competitive Benchmarking

    33. Global Ankylosing Spondylitis Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Ankylosing Spondylitis Market

    35. Ankylosing Spondylitis Market Future Outlook and Potential Analysis

    35.1 Ankylosing Spondylitis Market In 2028 - Countries Offering Most New Opportunities

    35.2 Ankylosing Spondylitis Market In 2028 - Segments Offering Most New Opportunities

    35.3 Ankylosing Spondylitis Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Ankylosing Spondylitis Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Ankylosing Spondylitis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Ankylosing Spondylitis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Global Ankylosing Spondylitis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: Asia-Pacific, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: China, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: India, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Japan, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Australia, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: Indonesia, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: South Korea, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: Western Europe, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: UK, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: Germany, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: France, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Italy, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Spain, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Eastern Europe, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: Russia, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: North America, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: USA, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: Canada, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: South America, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Brazil, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Middle East, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Africa, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 76: Pfizer Inc. Financial Performance
  • Table 77: Johnson & Johnson Pvt. Ltd. Financial Performance
  • Table 78: Merck & Co. Inc. Financial Performance
  • Table 79: AbbVie Inc. Financial Performance
  • Table 80: Novartis AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Ankylosing Spondylitis Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Ankylosing Spondylitis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Ankylosing Spondylitis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Global Ankylosing Spondylitis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: Asia-Pacific, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: China, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: India, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Japan, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Australia, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: Indonesia, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: South Korea, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: Western Europe, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: UK, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: Germany, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: France, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Italy, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Spain, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Eastern Europe, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: Russia, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: North America, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: USA, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: Canada, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: South America, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Brazil, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Middle East, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Africa, Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 76: Pfizer Inc. Financial Performance
  • Figure 77: Johnson & Johnson Pvt. Ltd. Financial Performance
  • Figure 78: Merck & Co. Inc. Financial Performance
  • Figure 79: AbbVie Inc. Financial Performance
  • Figure 80: Novartis AG Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report